The Genetic Testing Market has become a rapidly expanding segment of the global healthcare and biotechnology industries. Genetic testing involves analyzing DNA to identify genetic variations, mutations, or inherited conditions that may affect an individual’s health. As healthcare systems increasingly shift toward personalized and preventive care, genetic testing is emerging as a...
The companion diagnostics market is becoming increasingly important as healthcare moves from broad treatment approaches toward precision medicine and biomarker-guided therapies. The market was valued at USD 9.6 billion in 2025 and is projected to grow from USD 10.3 billion in 2026 to USD 20.1 billion by 2033, registering a CAGR of 10.1% from 2026 to 2033. Increasing demand for precision...
The proteomics market is entering a strong growth phase as advances in protein analysis, precision medicine, biomarker discovery, and clinical diagnostics expand its role across healthcare and life sciences. The market was valued at USD 38.4 billion in 2025 and is estimated to reach USD 43.7 billion in 2026, before growing to USD 97.7 billion by 2033, representing a CAGR of 12.2% from 2026 to...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek